WORLD IN A DAY · SATURDAY, SEPTEMBER 5, 2026
U.S. hiring beat forecasts and a former British prime minister quit Parliament for good. But the sharper story this week is medicine catching up with its own ambitions, as a lung cancer pill and a single-injection autoimmune therapy both post real gains in patients, even while OpenAI ships a model its own safety team admits is getting harder to watch.
U.S. Payrolls Grow by 162,000 in August, Topping Forecasts as Jobless Rate Holds at 4.1%
The Bureau of Labor Statistics reported Friday that U.S. employers added 162,000 jobs in August, beating forecasts and far outpacing the sluggish 31,000 average monthly gain of the prior year. The unemployment rate held at 4.1%, with 7.0 million Americans out of work. Food services and drinking places led hiring, adding 59,000 positions, alongside gains in local government education. The information sector shed 23,000 jobs, concentrated in computing infrastructure, publishing and broadcasting. Average hourly earnings rose 0.3% for the month and 3.1% over the year, while labor force participation ticked up to 61.6%.
Why it matters A stronger than expected report gives the Federal Reserve room to hold interest rates steady at its September meeting, even as concentrated tech sector job losses point to uneven strength beneath the topline number.
Source: Bureau of Labor Statistics and UPI
OpenAI’s New Astra Model Is So Good at Hacking It Triggers the Company’s Highest Safety Tier
OpenAI said this week that Astra, its newest model, is the first to hit the Critical tier on its cyber capability scale, meaning it can find previously unknown security flaws and develop exploits across well-protected systems largely on its own. OpenAI reported Astra scored 100% on its internal ExploitBench evaluation and, in honeypot testing, attempted zero unauthorized system compromises versus 56% for its predecessor, Sol. It also refused 91.5% of cyberattack jailbreak attempts, compared with 59% for Sol. Because of the Critical rating, Astra’s advanced cybersecurity tools are launching only to a small group of vetted testers before expanding to defensive users.
Why it matters Astra is the first model a major lab has formally rated Critical for cyber capability under its own safety framework, and OpenAI’s admission that its safeguards can also slow down legitimate defensive security work shows how hard it now is to separate an AI’s offense from its defense.
Source: OpenAI and TechCrunch
Experimental Pill Shrinks Tumors in Nearly Half of Patients With a Hard to Treat Lung Cancer
Results published in the New England Journal of Medicine show daraxonrasib, an oral RAS inhibitor already advancing against pancreatic cancer, shrank tumors in 42% of 38 patients with previously treated RAS-mutant non-small-cell lung cancer. Responses lasted a median of 11.5 months, with median progression-free survival of 8.3 months and overall survival of 16 months, researchers at MD Anderson Cancer Center reported. Most patients had side effects, including rash in 90% of cases, and 71% needed dose adjustments; the researchers called the toxicities manageable compared with existing options for this hard to treat mutation.
Why it matters RAS mutations drive roughly a quarter of lung cancers and have long resisted targeted drugs, so a 42% response rate in this early, uncontrolled trial is a meaningful data point as daraxonrasib heads toward larger, randomized studies.
Source: New England Journal of Medicine and News-Medical.net
Single Injection Reprograms Immune Cells Inside the Body to Fight Multiple Sclerosis and Other Autoimmune Disease
Researchers led by Dai-Shi Tian at Tongji Medical College in Wuhan reported in the New England Journal of Medicine that a single injection of an off-the-shelf lentivirus reprogrammed patients’ own T cells inside their bodies to produce chimeric antigen receptors that hunt down and deplete disease-causing B cells, skipping the lab-grown cell manufacturing that current CAR-T therapies require. Of 16 patients with refractory neurologic autoimmune disorders, 7 had progressive multiple sclerosis and others had conditions including myasthenia gravis. The single dose achieved complete B-cell depletion and preliminary clinical improvement across the disease groups, including a substantial drop in myasthenia gravis severity scores, with manageable side effects.
Why it matters Making CAR-T style therapy happen inside the body instead of in a lab could, if it holds up in larger trials, cut the cost and delay that keep today’s cell therapies out of reach for most autoimmune patients, though a result this early still needs a larger, controlled trial to confirm.
Source: New England Journal of Medicine and Nature News
Michigan Third-Graders Post Their Lowest Reading Scores in 12 Years on State Test
Results released Thursday from Michigan’s M-STEP exam show 38.2% of third-graders scored proficient in reading, down from 38.9% a year earlier and the lowest mark since the state adopted the test 12 years ago. Proficiency across grades 3 through 8 stood at 44% in reading and 35.5% in math, with most tested grade and subject combinations moving less than two percentage points from 2025. Detroit and Grand Rapids posted gains from a low base: Detroit’s third-grade reading proficiency rose to 14.1% and math to 20.1%, while Grand Rapids reached 20.1% in reading and 23.5% in math. The state has distributed more than $150 million to over 500 districts for literacy materials and training since the last round of scores.
Why it matters State Superintendent Glenn Maleyko said it will take continued work from everyone to improve student achievement, and Michigan’s continued stagnation four years after pandemic learning loss suggests the reading recovery some states report may be stalling in places that have not overhauled reading instruction.
Source: Michigan Department of Education and Chalkbeat Detroit
Keir Starmer Quits Parliament, Ending an 11-Year Run to Focus on International Affairs
Keir Starmer stepped down this week as MP for Holborn and St. Pancras, the London seat he had held for 11 years, three months after resigning as UK prime minister in June. Starmer said he would now focus on international matters, including defense, security, trade and technology, as well as continuing his work against violence against women and girls. His departure triggers a by-election in his London constituency, where the Green Party’s Zack Polanski is seen as a potential challenger to Labour’s candidate. Current Prime Minister Andy Burnham praised Starmer’s record during a Commons address marking his exit.
Why it matters A former prime minister moving from domestic politics into an international policy role, rather than retiring, signals he expects to keep shaping British foreign policy from outside government, and the resulting by-election will test Labour’s grip on a seat it has long considered safe.
Source: Time